x min read

Why Need to Watch: Gilead Sciences Inc. (NASDAQ:GILD), Solazyme (NASDAQ:SZYM), Universal Health Realty Income Trust (NYSE:UHT), Isis Pharmaceuticals (NASDAQ:ISIS), DreamWorks Animation (NASDAQ:DWA)

Why Need to Watch: Gilead Sciences Inc. (NASDAQ:GILD), Solazyme (NASDAQ:SZYM), Universal Health Realty Income Trust (NYSE:UHT), Isis Pharmaceuticals (NASDAQ:ISIS), DreamWorks Animation (NASDAQ:DWA)
Written by
Charles Donlon
Published on
November 10, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

Johnson & Johnson (JNJ) won U.S. approval for its hepatitis C drug Olysio to be used in combination with Gilead Sciences Inc. (NASDAQ:GILD)’s Sovaldi, making it the second all-oral treatment available for the most common form of the virus. Gilead Sciences Inc. (NASDAQ:GILD) belongs to Healthcare sector. Its net profit margin is 45.40% and weekly performance is -4.96%. On last trading day company shares ended up $106.45. Gilead Sciences Inc. (NASDAQ:GILD) distance from 50-day simple moving average (SMA50) is 0.18%. Robert W. Baird downgraded shares of Solazyme (NASDAQ:SZYM) from an outperform rating to a neutral rating in a research note released on Thursday morning, TheFlyOnTheWall.com reports. They currently have $9.00 target price on the stock, down from their previous target price of $16.00. Solazyme, Inc. (NASDAQ:SZYM) shares increased 15.61% in last trading session and ended the day at $3.63. SZYM Gross Margin is 77.50% and its return on assets is -48.30%. Solazyme, Inc. (NASDAQ:SZYM) quarterly performance is -62.69%. On Oct. 23, Universal Health Realty Income Trust (NYSE:UHT) announced that for the three-month period ended September 30, 2014, reported net income was $28.1 million, or $2.18 per diluted share, as compared to $3.3 million, or $.26 per diluted share, during the third quarter of 2013. On 07 November, Universal Health Realty Income Trust (NYSE:UHT) shares increased 0.64% and was closed at $48.54. UHT EPS growth in last 5 year was 1.20%. Universal Health Realty Income Trust (NYSE:UHT) year to date (YTD) performance is 26.54%. Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) reported a wider loss for the third quarter, hurt by increased expenses, even as research and development revenue under collaborative agreements gained momentum. Loss for the quarter was more than Wall Street estimates, with revenues also coming in short of expectations. Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) belongs to Healthcare sector. Its net profit margin is -61.10% and weekly performance is -3.19%. On last trading day company shares ended up $44.59. Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) distance from 50-day simple moving average (SMA50) is 9.30%. On Oct 29, A visit to Santa at the local mall is getting an overhaul this Christmas, with some help from DreamWorks Animation SKG Inc. (NASDAQ:DWA) and its biggest star, Shrek. Jeffrey Katzenberg’s independent film studio is bringing DreamWorks DreamPlace to eight U.S. malls starting on Nov. 6. The attraction, DreamWorks executives say, will allow parents and kids to personalize their visit to the North Pole and do away with the lines and crowds. DreamWorks Animation SKG Inc. (NASDAQ:DWA) shares increased 0.36% in last trading session and ended the day at $22.24. DWA Gross Margin is 23.70% and its return on assets is -1.40%. DreamWorks Animation SKG Inc. (NASDAQ:DWA) quarterly performance is 10.70%.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.